Green Square Capital Advisors LLC Astrazeneca PLC Transaction History

Green Square Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $537,460 - $651,494	-15,144 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $23,184 - $26,097	-629 Reduced 3.99%	15,144 $575,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $53,530 - $61,168	1,540 Added 10.82%	15,773 $624,000
Q2 2018 Aug 20, 2018	BUY	$34.55 - $37.05 $53,828 - $57,723	1,558 Added 12.29%	14,233 $500,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $227,558 - $252,820	6,902 Added 119.56%	12,675 $443,000
Q4 2017 Feb 22, 2018	BUY	$32.09 - $34.78 $185,255 - $200,784	5,773	5,773 $200,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Green Square Capital Advisors LLC with notifications on news.